Keyphrases
Polyps
100%
Thrombosis
100%
Hemostasis
100%
Heparin Reversal
85%
Reversal Agents
85%
Procoagulant Activity
28%
Bleeding
28%
Polycationic
28%
Mouse Model
14%
Polyethylenimine
14%
Primary Amines
14%
In Vitro Activity
14%
Novel Class
14%
Heparin
14%
New Platform
14%
Polyamidoamine (PAMAM)
14%
Reduced Toxicity
14%
Binding Ability
14%
Test Administration
14%
Equivalent Dose
14%
Polymyxin B
14%
Toxicity in Vivo
14%
Multiple Primary
14%
Anionic Polymer
14%
Activated Platelets
14%
Bleeding Test
14%
Antithrombotic Therapy
14%
Mouse Tail
14%
Arterial Thrombosis
14%
Antithrombotic Target
14%
Antithrombotic Agents
14%
Tail Bleeding
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
100%
Polyphosphate
100%
Thrombosis
100%
Blood Stasis
100%
Procoagulant
42%
Anticoagulant Agent
42%
Side Effect
14%
Mouse Model
14%
Polyethyleneimine
14%
Dendrimer
14%
Bleeding
14%
Polymyxin B
14%
Artery Thrombosis
14%
Poly(amidoamine)
14%